| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4166 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2018-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9579c1bf09ef2160d6d13194956afe4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99b5baf18836d8c811709cc7029377d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99b9da43961612f71fbefc668174fddd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b29e117a134721cc264b0c236e13c0ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdfe5239aea8000a8568ef366ba96863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf257657174d431ee52c7b7dd1ab48dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c2348879bf770b1061c3dd41141bc40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc6e5bbcef706ebab894eb4f98c1433f |
| publicationDate |
2019-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2018256998-A1 |
| titleOfInvention |
Pharmaceutical composition for oral administration comprising |
| abstract |
Provided is an orally administrable pharmaceutical composition in which the dissolution and/or elution properties of enzalutamide are improved and supersaturation is maintained. Also provided is an orally administrable pharmaceutical composition in which the oral absorbability of enzalutamide is improved. The orally administrable pharmaceutical composition contains enzalutamide and polyvinyl alcohol. |
| priorityDate |
2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |